Skip to main content

Animations

MJFF Publications

8371 - 8380 of 8808 Results
Title
Year
  • Year
  • 2023
  • 2017
  • 2022
  • 2024
  • 2025
  • 2016
  • 2025
  • 2021
  • 2019
  • 2022
  • Summary Details
    OPEN
    Title: Comparative analysis of methods to reduce activation signature gene expression in PBMCs
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-49611-2
    Citation Count: 6
  • Summary Details
    OPEN
    Title: The End Is the Beginning: Parkinson’s Disease in the Light of Brain Imaging
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2017.00330
    Citation Count: 34
  • Summary Details
    OPEN
    Title: The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.049192
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Pathogenetic Contributions and Therapeutic Implications of Transglutaminase 2 in Neurodegenerative Diseases
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms25042364
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Baseline α-synuclein seeding activity and disease progression in sporadic and genetic Parkinson's disease in the PPMI cohort
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105866
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Dysregulation of protein phosphatase 2A in parkinson disease and dementia with lewy bodies
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.337
    Citation Count: 60
  • Summary Details
    OPEN
    Title: Alpha-synuclein abundance and localization are regulated by the RNA-binding protein PUMILIO1
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.celrep.2025.116145
    Citation Count: 1
  • Summary Details
    OPEN
    Title: T-cell based immunotherapies for Parkinson’s disease
    Journal Name: Exploration of Neuroprotective Therapy
    Publisher: Open Exploration Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.37349/ent.2021.00007
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.104577
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-022-34732-5
    Citation Count: 56
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.